Ausgabe 1/2011
Inhalt (14 Artikel)
Clinical Trial Report: TMC278 (Rilpivirine) Versus Efavirenz as Initial Therapy in Treatment-Naïve, HIV-1–Infected Patients
Rodger D. MacArthur
Probiotics and Prebiotics for the Prevention of Necrotizing Enterocolitis
Michael R. Stenger, Kristina M. Reber, Peter J. Giannone, Craig A. Nankervis
Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection
Nuntra Suwantarat, David A. Bobak
Current Concepts of the Intestinal Microbiota and the Pathogenesis of Infection
Leslie H. Wardwell, Curtis Huttenhower, Wendy S. Garrett
Update on Strongyloidiasis in the Immunocompromised Host
Luis A. Marcos, Angélica Terashima, Marco Canales, Eduardo Gotuzzo
Current Views on the Pathophysiology of GB Virus C Coinfection with HIV-1 Infection
Esaki Muthu Shankar, Pachamuthu Balakrishnan, Ramachandran Vignesh, Vijayakumar Velu, Palanisamy Jayakumar, Suniti Solomon
Posttransplant Lymphoproliferative Disease in Liver Transplant Patients
Christina Hartmann, Marcus Schuchmann, Tim Zimmermann
The Rapidly Evolving Research on Vitamin D Among HIV-Infected Populations
Edgar Turner Overton, Michael T. Yin
Prospects for Development of a Vaccine to Prevent and Control Vaginal Candidiasis
Paul L. Fidel Jr., Jim E. Cutler